Funded Tech Companies
Antiva Biosciences
Headquartered in Del Mar, Antiva Biosciences has funding from GV, BioImpact Capital and Canaan Partners.
Company Overview
Company Name
Antiva Biosciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Company Background Information
Overview
Antiva Biosciences was founded by Karl Hostetler, M.D., a leader in virology who founded Chimerix, Triangle Therapeutics (acquired by Gilead) and Vical. The company is using a new medicinal chemistry platform to develop antiviral therapies, focusing first on HPV. Antiva has additional molecules that target HIV, the herpes virus, cytomegalovirus and others.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/27/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Founder
Karl Hostetler
Company Investors
- GV
- BioImpact Capital
- Canaan Partners (Wende Hutton)
- Lumira Ventures
- Sofinnova Ventures (David Kabakoff)
- Adjuvant Capital
- Brace Pharma (Vinzenz Ploerer)
- Hillhouse Capital Group
- Osage Partners
- Sirona Capital
- Lumira Capital
- Alexandria Venture Investments
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs